Slash Heart Attack Risk By 43%? (You Can Start Today)

Once you reach a certain age, you start paying a lot more attention to your heart health.

And if you’re struggling with kidney problems, that should be especially true.

Did you know the #1 killer of people on dialysis isn’t kidney failure – it’s heart disease?

But Australian researchers have found an incredibly simple way for dialysis patients to slash their heart attack and stroke risk by a whopping 43%.

It could literally save the life of you or someone you love.

And, trust me, it’ll still work even if your kidneys are perfectly healthy.

Australian researchers recently wrapped up the PISCES trial, which included more than 1,200 patients at 26 different dialysis sites.

It turned out the folks who supplemented with 4 g. of fish oil a day had a 43% lower risk of heart attack, stroke, and cardiac death.

Fish oil directly targeted the leading killers of people on dialysis.

And, really, I’m not surprised. Fish oil is a rich source of omega-3 fatty acids like DHA and EPA.

It’s been repeatedly shown to help lower triglycerides and inflammation, two serious risk factors for heart attack and stroke.

Beyond that, DHA helps support the mitochondria – the energy centers of our cells. And the heart is a very energy-hungry organ.

Now, this is great – and maybe even lifesaving – news for dialysis patients. But omega-3s can deliver benefits for just about anyone.

If you’ve been reading my eletter for a while, you know that I prefer you get your omega-3s from food. I eat fish multiple times a week, often fish I catch myself.

But there are blood tests you can request like OmegaCheck that can tell if you’re seriously deficient, and whether supplementing might make sense.

View Sources

Charmaine E. Lok, Michael Farkouh, Brenda R. Hemmelgarn, Louise M. Moist, Kevan R. Polkinghorne, George Tomlinson, Paul Tam, Marcello Tonelli, Jacob A. Udell. Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis. New England Journal of Medicine, 2026; 394 (2): 128 DOI: 10.1056/NEJMoa2513032